The most important market moving news for the week ending April 23, 2021.

Caplin Steriles Limited, a subsidiary company of Caplin Point Laboratories Limited announced this morning that it has been granted approval from USFDA for its abbreviated new drug application (ANDA) Prochlorperazine Edisylate injection USP, 10 mg/2 ml (5 mg/ml) vials presentations.

Considering the most important assumption in technical analysis i.e. 'history tends to repeat itself’, we believe that a similar quantum of moves is on cards.

Tata Elxsi is turning out to be a star performer from the pack of Tata Group stocks. The stock jumped more than eight per cent on Friday, trading at Rs 3,291.55 per share.   

On Friday, Alembic Pharmaceuticals informed the exchanges that it has received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Doxepin Hydrochloride capsules, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg & 100 mg.  

Indian markets were trading near the lowest point of the day with Nifty and Sensex slipping by half a per cent. 

Kameda Seika, Japan’s largest rice crackers company as well as LT Foods’ joint venture company has started exporting Kari Kari in the markets of Australia & UAE.

Gland Pharma Limited announced after the market hours on Thursday that it has received approval from United States Food & Drug Administration (USFDA) for generic Foscarnet Sodium injection, 6,000 mg/250 ml (24 mg/ml) single-dose bag for infusion.

In just one year, Orient Refractories Limited has rallied by approximately 147 per cent making an all-time high level of Rs 319.20 from its 52-week low level of Rs 129.50 on BSE. On a YTD basis, this stock has given approximately 27 per cent returns to the investors. 

The market opened in red on April 23, 2021.